This site is intended for healthcare professionals
News

Leo Pharma files at FDA a BLA for tralokinumab to treat moderate-to-severe atopic dermatitis.

Read time: 1 mins
Last updated:13th Jul 2020
Published:13th Jul 2020
Condition: Atopic Dermatitis (Eczema)
Type: drug
Register free for full access to medthority.com